ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Telesis Bio Inc

Telesis Bio Inc (TBIO)

3.23
0.00
( 0.00% )
Updated: 18:00:00

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
3.23
Bid
3.15
Ask
3.35
Volume
-
0.00 Day's Range 0.00
1.27 52 Week Range 15.462
Market Cap
Previous Close
3.23
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
1,357,638
Shares Outstanding
1,775,839
Dividend Yield
-
PE Ratio
-0.12
Earnings Per Share (EPS)
-27.61
Revenue
27.51M
Net Profit
-49.02M

About Telesis Bio Inc

Telesis Bio Inc. is engaged in providing automated multi-omic and synthetic biology solutions. The Company's synthetic biology solution addresses the bottlenecks across the multi-step process of building deoxyribonucleic acid (DNA) and messenger ribonucleic acid (mRNA), as well as the limitations of... Telesis Bio Inc. is engaged in providing automated multi-omic and synthetic biology solutions. The Company's synthetic biology solution addresses the bottlenecks across the multi-step process of building deoxyribonucleic acid (DNA) and messenger ribonucleic acid (mRNA), as well as the limitations of solutions that prevent the building of virtually error-free DNA and mRNA at a useable scale. Its on-market and planned solutions include BioXp 3250 system, BioXp 9600 system, BioXp DBC, BioXp portal, BioXp De Novo kits, BioXp Select kits, BioXp Next Generation Sequencing kits, BioXp DBC kits, Benchtop reagents and Short Oligo Ligation Assembly (SOLA) enzymatic DNA synthesis (EDS). BioXp 3250 system is a push-button, walkaway, end-to-end automated workstation that offers endpoint-ready synthetic DNA in as few as 8 hours and mRNA in less than 24 hours. BioXp DBC is engaged in delivering on-demand enzymatic DNA synthesis with design-to-endpoint-ready synthetic RNA in as few as 24 hours. Show more

Sector
Lab Analytical Instruments
Industry
Lab Analytical Instruments
Headquarters
Wilmington, Delaware, USA
Founded
-
Telesis Bio Inc is listed in the Lab Analytical Instruments sector of the NASDAQ with ticker TBIO. The last closing price for Telesis Bio was US$3.23. Over the last year, Telesis Bio shares have traded in a share price range of US$ 1.27 to US$ 15.462.

Telesis Bio currently has 1,775,839 shares outstanding. The market capitalization of Telesis Bio is US$5.74 million. Telesis Bio has a price to earnings ratio (PE ratio) of -0.12.

TBIO Latest News

Telesis Bio and Beckman Coulter Life Sciences Collaborate to Revolutionize DNA and mRNA Synthesis

SAN DIEGO, Sept. 25, 2024 (GLOBE NEWSWIRE) -- A new partnership between Telesis Bio and Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, will create...

Telesis Bio Plans to Delist its Securities fromΒ The Nasdaq Stock Market

SAN DIEGO, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO) (β€œTelesis” or the β€œCompany”), a leading provider of RNA and DNA solutions enabling researchers to accelerate...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1003.233.233.2300CS
4003.233.233.2300CS
12-0.62-16.10389610393.855.081.2713576383.2295393CS
26-0.85-20.83333333334.086.061.276957493.33275371CS
52-4.4272-57.8174789747.657215.4621.275650876.00580343CS
156-669.25-99.5196883179672.48672.481.272324869.56490266CS
260-178.57-98.2233223322181.8683.731.27593987326.24823147CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SNTISenti Biosciences Inc
US$ 14.06
(550.93%)
73.4M
PPBTPurple Biotech Ltd
US$ 7.22
(115.20%)
20.14M
FOSLFossil Group Inc
US$ 2.44
(67.12%)
8.49M
PRZOParaZero Technologies Ltd
US$ 1.859
(49.92%)
61.29M
JCSEJE Cleantech Holdings Limited
US$ 1.72
(44.54%)
10.31M
MONDMondee Holdings Inc
US$ 0.453499
(-36.14%)
663.26k
SDOTSadot Group Inc
US$ 4.0828
(-22.23%)
287.45k
WAITop KingWin Ltd
US$ 0.4122
(-21.38%)
1.23M
LGHLWLion Group Holding Ltd
US$ 0.007
(-21.35%)
25.7k
INVZWInnoviz Technologies Ltd
US$ 0.0759
(-20.11%)
1.93k
XTIAXTI Aerospace Inc
US$ 0.0476
(6.01%)
115.93M
SNTISenti Biosciences Inc
US$ 14.1899
(556.94%)
74.57M
RGTIRigetti Computing Inc
US$ 3.2797
(7.53%)
72.45M
SGBXSafe and Green Holdings Corporation
US$ 0.6285
(28.27%)
69.79M
SMCISuper Micro Computer Inc
US$ 38.215
(17.08%)
64.7M

TBIO Discussion

View Posts
Renee Renee 2 months ago
TBIO delisted from the Nasdaq to the OTC:

https://otce.finra.org/otce/dailyList?viewType=Additions
πŸ‘οΈ0
Invest-in-America Invest-in-America 2 months ago
TBIO: See latest 'CHART' below!!! (Purest FLUFF "news", yesterday Post-M, in the entire history of Wall Street!!! Even going all the way back to Ben Franklin days, when he discovered & then Patented Electricity, with his KITE & house key!!!)

πŸ‘οΈ0
georgie18 georgie18 2 months ago
TBIO...$3.40...LOD...🥳
πŸ‘οΈ0
glenn1919 glenn1919 2 months ago
TBIO..................https://stockcharts.com/h-sc/ui?s=TBIO&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
Awl416 Awl416 2 months ago
I actually have no clue. Very well could be under the same umbrella

Seems as though same father company divided into two operations
πŸ‘οΈ0
Awl416 Awl416 2 months ago
I bet most ppl thought this was the company β€”> https://en.m.wikipedia.org/wiki/Beckman_Coulter

πŸ‘οΈ0
Awl416 Awl416 2 months ago
last trading day of the Common Stock on the Nasdaq Global Select Market will be on or about September 30, 2024
πŸ‘οΈ0
weedtrader420 weedtrader420 2 months ago
🤑🤑🤑
πŸ‘οΈ0
georgie18 georgie18 2 months ago
Just lucky to catch it at the right time...Thanks...🥳
πŸ‘οΈ0
tw0122 tw0122 2 months ago
Nice one .. SAN DIEGO, Sept. 25, 2024 (GLOBE NEWSWIRE) -- A new partnership between Telesis Bio and Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, will create efficient and scalable biofoundries, delivering solutions for sustainable and rapid on-premise synthesis of DNA. This innovative approach enabled by Telesis Bio’s Gibson SOLA enzymatic reagent platform running on Beckman Coulter Life Sciences automation to ensures rapid, reliable, and highly scalable production of extremely high-fidelity DNA, empowering researchers to achieve greater productivity and innovation in a wide array of discovery applications.
πŸ‘οΈ0
georgie18 georgie18 2 months ago
TBIO...$5.60s clearing here...🥳

TBIO...$4.90s...clearing here...🥳

georgie18

Member Level
Re: None

Wednesday, September 25, 2024 4:11:51 PM

Post#
37
of 37
TBIO...$3.82...Moving on strong news...🥳https://www.globenewswire.com/news-release/2024/09/25/2953354/0/en/Telesis-Bio-and-Beckman-Coulter-Life-Sciences-Collaborate-to-Revolutionize-DNA-and-mRNA-Synthesis.html
πŸ‘οΈ0
georgie18 georgie18 2 months ago
TBIO...$4.90s...clearing here...🥳

georgie18

Member Level
Re: None

Wednesday, September 25, 2024 4:11:51 PM

Post#
37
of 37
TBIO...$3.82...Moving on strong news...🥳https://www.globenewswire.com/news-release/2024/09/25/2953354/0/en/Telesis-Bio-and-Beckman-Coulter-Life-Sciences-Collaborate-to-Revolutionize-DNA-and-mRNA-Synthesis.html
πŸ‘οΈ0
georgie18 georgie18 2 months ago
TBIO...$3.82...Moving on strong news...🥳https://www.globenewswire.com/news-release/2024/09/25/2953354/0/en/Telesis-Bio-and-Beckman-Coulter-Life-Sciences-Collaborate-to-Revolutionize-DNA-and-mRNA-Synthesis.html
πŸ‘οΈ0
TheFinalCD TheFinalCD 2 months ago
https://x.com/M1000Sahm/status/1836685386396873051
πŸ‘οΈ0
Awl416 Awl416 2 months ago
Don’t forget it’s getting delisted tomorrow
πŸ‘οΈ0
glenn1919 glenn1919 2 months ago
tbio................................https://stockcharts.com/h-sc/ui?s=TBIO&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
TimeFades TimeFades 2 months ago
Wow field day
πŸ‘οΈ0
tw0122 tw0122 2 months ago
TBIO $3.40 + 150% cash out time pump time over
πŸ‘οΈ0
tw0122 tw0122 2 months ago
TBIO 3.80 + 180% push it more honest hedge funds we luv it
πŸ‘οΈ0
tw0122 tw0122 2 months ago
Pump it more $3.20 + 120% now. I luv Gary Gensler
πŸ‘οΈ0
tw0122 tw0122 2 months ago
Pump it up
πŸ‘οΈ0
Awl416 Awl416 3 months ago
Telesis Bio Plans to Delist its Securities from The Nasdaq Stock Market
πŸ‘οΈ0
Awl416 Awl416 4 months ago
What’s the deal with this sucker
πŸ‘οΈ0
Awl416 Awl416 4 months ago
Lol
πŸ‘οΈ0
Awl416 Awl416 4 months ago
Don’t blink
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 5 months ago
somebody is getting smoked here
πŸ‘οΈ0
tw0122 tw0122 5 months ago
5.50s
πŸ‘οΈ0
observer21 observer21 6 months ago
Anyone have a clue as to why the jump today?
πŸ‘οΈ0
TOM611 TOM611 9 months ago
Go. TBiO. Life. Enhancing. Patent
πŸ‘οΈ0
Hikiro Hikiro 9 months ago
I personally see this consolidating Monday between .55 and .45
πŸ‘οΈ0
glenn1919 glenn1919 9 months ago
TBIO...............................................https://stockcharts.com/h-sc/ui?s=TBIO&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
XenaLives XenaLives 9 months ago
This one scares the crap out of me...

Imagine replication of COVID ( or the next worst thing) with out a biological matrix.

December 5, 2023 | LIVE WEBINAR
Unlocking the Potential of mRNA as a Tool for Immuno-Oncology Therapy Discovery and Development
Immuno-oncology is a rapidly growing area for therapeutic development. With the adoption of various autologous cell therapies and an increased focus on more broadly applicable allogeneic treatments and multi-specific therapies, the complexity of these development activities is also increasing. With this drive to increased complexity and the inherent risks associated with potential failure in Phase 1 clinical trials, it is critical to have a solid scientific foundation for the development of these next-generation immunotherapies. This talk will focus on how to overcome the limitations associated with traditional viral vector based recombinant TCR gene expression to build hundreds of candidates a week, resulting in improved confidence in screening and lead optimization. With the direct use of mRNA to drive transient modulation of cellular phenotypes, potential candidates can be screened quickly and cost-effectively. Come and learn how immuno-oncology researchers are automating synthetic biolological...



$TBIO Granted EUR Patent #3503915 For "GENETICALLY ENGINEERED VIBRIO NATRIEGENS (HOST ORGANISM FOR CLONING AND MANIPULATING DNA)".https://t.co/9dekeJkgGu pic.twitter.com/Mj3hMaJPML— Patent_Stocks (@US_Patent_Plays) February 22, 2024
πŸ‘οΈ0
TOM611 TOM611 9 months ago
Wow, a patent to clone that’s incredible
πŸ‘οΈ0
observer21 observer21 9 months ago
Gosh. Such wisdom. Thanks for enlightening us with that critical information.
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 9 months ago
dilutive bio stocks under 1.00 are like pink sheets on steroids...ya better know how to trade em or you will lose yo money fast!!!
πŸ‘οΈ0
Invest-in-America Invest-in-America 9 months ago
TBIO: Right here in my San Diego --- grab some?????
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 9 months ago
Chart plays are never tricky. Stick to bullish stocks. Day trading pop and drops, ya better have skills and understand intraday 60 min charting, order flow and how to spot the shorts.
πŸ‘οΈ0
TimeFades TimeFades 9 months ago
Tricky day
πŸ‘οΈ0
Awl416 Awl416 9 months ago
New highs AH
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 9 months ago
LETS JUST SAY MOST AH POPS ARE DILUTION, ESPECIALLY THE BIO SPACE.
πŸ‘οΈ0
TheFinalCD TheFinalCD 9 months ago
THX
πŸ‘οΈ0
TimeFades TimeFades 9 months ago
Another short opp
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 9 months ago
AFTER HOUR DILUTION TAKING PLACE...CHASE AND CRY PLAY!
πŸ‘οΈ0
Awl416 Awl416 9 months ago
What leaked?
πŸ‘οΈ0
Zorro Zorro 9 months ago
Nice one!
πŸ‘οΈ0
Invest-in-America Invest-in-America 9 months ago
TBIO: VIBRIO NATRIEGENS (So, what's NEW, Pussycat??!!)

πŸ‘οΈ0
TheFinalCD TheFinalCD 9 months ago
https://twitter.com/US_Patent_Plays/status/1760770637251928392
πŸ‘οΈ0
observer21 observer21 10 months ago
Anyone know why the huge jump in price and volume?
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock